ThermoGenesis Holdings, Inc. (NASDAQ:THMO – Free Report) – Research analysts at HC Wainwright cut their Q3 2024 EPS estimates for ThermoGenesis in a note issued to investors on Tuesday, November 14th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings per share of $0.02 for the quarter, down from their previous forecast of $0.03. HC Wainwright currently has a “Buy” rating and a $5.00 price target on the stock. The consensus estimate for ThermoGenesis’ current full-year earnings is ($3.26) per share. HC Wainwright also issued estimates for ThermoGenesis’ FY2024 earnings at $0.08 EPS.
ThermoGenesis Price Performance
Shares of ThermoGenesis stock opened at $0.99 on Wednesday. The firm has a fifty day moving average price of $1.14 and a 200 day moving average price of $1.31. ThermoGenesis has a 1 year low of $0.90 and a 1 year high of $6.75.
Institutional Investors Weigh In On ThermoGenesis
ThermoGenesis Company Profile
ThermoGenesis Holdings, Inc develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
- Five stocks we like better than ThermoGenesis
- How to Calculate Stock Profit
- 3 value stocks you shouldn’t let go of this quarter
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 5 must-have next-gen technologies that institutions are buying
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 intriguing late-week earnings plays for short-term traders
Receive News & Ratings for ThermoGenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ThermoGenesis and related companies with MarketBeat.com's FREE daily email newsletter.